Shareholder's equity

12 Months Ended

Dec. 31, 2024

Stockholders' Equity Note [Abstract]

Shareholders' equity

14. Shareholders’ equity

Dividends

The Company has not historically paid dividends to holders of its common stock. Certain subsidiaries of the Company have restrictions on their ability to pay dividends in certain circumstances pursuant to the Credit Agreement. In the event that the Company decides to pay a dividend to holders of its common stock in the future with dividends received from its subsidiaries, the Company may, based on prevailing rates of taxation, be required to pay additional withholding and income tax on such amounts received from its subsidiaries.

Accumulated Other Comprehensive Income (Loss)

Accumulated other comprehensive income (loss) is comprised of foreign currency translation adjustments and unrealized gains (losses) on available for sale debt securities. The Company’s policy is to release income tax effects related to items recognized within accumulated other comprehensive income (loss) using a portfolio approach. The components of and changes in accumulated other comprehensive income (loss) are as follows:

(U.S. Dollars, in thousands)	Currency Translation Adjustments			Neo Medical Convertible Loans			Other Investments			Accumulated Other Comprehensive Income (Loss)
Balance at December 31, 2021	$	(711	)	$	711		$	—		$	—
Other comprehensive income (loss)		(1,771	)		294			101			(1,376	)
Income taxes		—			—			—			—
Balance at December 31, 2022	$	(2,482	)	$	1,005		$	101		$	(1,376	)
Other comprehensive income (loss)		1,417			(1,233	)		(101	)		83
Income taxes		—			—			—			—
Balance at December 31, 2023	$	(1,065	)	$	(228	)	$	—		$	(1,293	)
Other comprehensive income (loss)		(3,009	)		1,671			—			(1,338	)
Income taxes		—			—			—			—
Reclassification adjustment to:
Other expense, net		—			(1,671	)		—			(1,671	)
Balance at December 31, 2024	$	(4,074	)	$	(228	)	$	—		$	(4,302	)